Fujimoto Ayame, Fu Rong, Noguchi Haruko, Maruyama Shiko, Nakamura Sayaka
Waseda Institute of Social and Human Capital Studies, Tokyo, Japan.
Faculty of Commerce, Waseda University, Tokyo, Japan
BMJ Open. 2025 May 21;15(5):e093601. doi: 10.1136/bmjopen-2024-093601.
To examine how relationships between physicians, pharmacists and patients associate with generic drug (GE) utilisation in Japan's healthcare system.
Observational study using longitudinal medical claims from April 2015 to March 2021.
Pharmacies across Japan serving beneficiaries of the National Health Insurance Association.
69 395 pharmacies, resulting in 322 097 pharmacy-year observations.
Quantity share of GEs dispensed by pharmacies.
Higher hospital prescription concentration was consistently associated with increased GE usage (1.1-2.3 percentage points higher for moderate to very high concentrations compared with low). The relationship between patient prescription concentration and GE usage varied, showing a positive association (0.3-0.6 percentage points higher) overall, but negative in settings with low hospital concentration. Smaller pharmacies exhibited a stronger positive association between hospital concentration and GE usage, while larger pharmacies and those in less urbanised areas showed a stronger positive association between patient concentration and GE usage.
This study reveals that pharmacy-stakeholder relationships significantly influence GE utilisation in Japan's healthcare system. Our findings demonstrate that hospital-pharmacy relationships consistently drive generic usage, while patient-pharmacy relationships show contextual effectiveness. By measuring these relationships through concentration rates, we provide evidence that stakeholder interactions may affect medication dispensing decisions. These findings suggest that policies promoting GEs may benefit from considering the specific characteristics of pharmacies and their existing relationships with hospitals and patients. These insights can inform more effective policy design for GE promotion across different healthcare contexts.
研究在日本医疗体系中,医生、药剂师和患者之间的关系如何与通用药物(GE)的使用相关联。
利用2015年4月至2021年3月的纵向医疗理赔数据进行观察性研究。
日本各地为国民健康保险协会受益人服务的药店。
69395家药店,产生了322097个药店年度观察数据。
药店配出的通用药物的数量占比。
医院处方集中度越高,与通用药物使用量增加始终相关(与低集中度相比,中度至非常高集中度时通用药物使用量高1.1 - 2.3个百分点)。患者处方集中度与通用药物使用之间的关系各不相同,总体呈正相关(高0.3 - 0.6个百分点),但在医院集中度低的环境中呈负相关。规模较小的药店在医院集中度与通用药物使用之间呈现出更强的正相关,而规模较大的药店以及城市化程度较低地区的药店在患者集中度与通用药物使用之间呈现出更强的正相关。
本研究表明,在日本医疗体系中,药店利益相关者之间的关系对通用药物的使用有显著影响。我们的研究结果表明,医院与药店的关系始终推动通用药物的使用,而患者与药店的关系则显示出情境有效性。通过集中度来衡量这些关系,我们提供了证据表明利益相关者的互动可能会影响药物配给决策。这些发现表明,推广通用药物的政策可能受益于考虑药店的具体特征及其与医院和患者的现有关系。这些见解可为不同医疗环境下更有效的通用药物推广政策设计提供参考。